Oral β-blocker treatment showed no association with all-cause mortality in contemporary post-myocardial infarction patients.
Does oral β-blocker treatment reduce all-cause mortality in contemporary post-myocardial infarction patients?
This meta-analysis suggests that routine oral beta-blocker treatment may not reduce all-cause mortality in contemporary post-myocardial infarction patients, highlighting the need for large randomized clinical trials.
Absolute Event Rate: 0% vs 0%
Evidence from this study suggests that there is no association between β-blockers and all-cause mortality. A possible beneficial effect in AMI survivors needs to be tested by large randomized clinical trials.
Aarvik et al. (Sun,) reported a other. Oral β-blocker treatment showed no association with all-cause mortality in contemporary post-myocardial infarction patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: